Sintilimab Combined with Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma in Second-Line Setting—A Multi-Center Observational Study

BACKGROUND: Patients with advanced intrahepatic cholangiocarcinoma (iCCA) have a poor prognosis and a substantial unmet clinical need. The study was aimed to investigate the efficacy and safety of sintilimab combined with lenvatinib for advanced iCCA in second-line setting. METHODS: The patients at...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Xiaoyan, Li, Guangxin, Sun, Wei, Shen, Yanjun, Teng, Ying, Xu, Yawen, Li, Wendong, Liu, Mei, Chen, Jinglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333059/
https://www.ncbi.nlm.nih.gov/pubmed/35912220
http://dx.doi.org/10.3389/fonc.2022.907055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333059/
https://www.ncbi.nlm.nih.gov/pubmed/35912220
http://dx.doi.org/10.3389/fonc.2022.907055

Ejemplares similares